Michal Sedlák

Michal Sedlák

Auto-generated profile, based on publicly available information

Michal Sedlák

Department of Biochemistry Faculty of Science Masaryk University Brno Czech Republic

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2026 in Journal of Separation Science
Verified
Journal Article
Open access
MSMichal Sedlák
Michal Sedlák
LKLenka Kohútová
Lenka Kohútová
MPMarta Pelcová
Marta Pelcová
ZGZdenek Glatz
Zdenek Glatz
This study presents a novel pressure‐assisted capillary electrochromatography method that uses a fritless capillary column of magnetic microparticles with immobilized serum albumin to investigate the affinity interactions of drugs with plasma proteins. To the authors' knowledge, this is the first time that this type of column has been used in a study examining the binding properties of a drug–serum albumin pair. The use of magnetic particles as the chromatographic bed material offers several advantages, such as easy handling during chemical activation and subsequent protein immobilization, and relatively simple column preparation achieved by external permanent magnets around the capillary. In addition, this concept is characterized by low protein and reagent consumption, which is typical for capillary electrochromatography. Glutaraldehyde coupling was chosen for its sufficient yield of immobilized bovine serum albumin (BSA) with preserved drug‐binding properties compared to the carbodiimide method. Furthermore, the required binding capacity was increased by optimizing the length of the particle bed, which was held in the capillary by 25 pairs of permanent magnets in an attractive orientation in a 3D‐printed holder positioned inside the capillary cartridge. After optimizing the immobilization procedure and the column preparation, the column was used to determine the binding parameters of the model drug phenylbutazone (PBZ) to the pharmacologically significant Sudlow I site on the BSA molecule. Frontal electrokinetic injection and breakthrough time analysis were employed for each PBZ concentration to estimate the corresponding equilibrium binding constant. The proposed approach could be particularly useful for studying the binding of drugs to expensive or rare proteins and support the choice of lead compounds in drug development studies.